Holdings
Blue Owl Capital Holdings LP
As of Sep 30, 2026, Blue Owl Capital Holdings LP reported 48 positions worth US$544M. Largest: Space Exploration Technologies Corp, Aktis Oncology, Inc. and Latigo Biotherapeutics, Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 48
- Value as reported
- US$544M
- Holdings as of
- Sep 30, 2026
- Last filed
- Nov 13, 2026
| Company | Shares | Value as reported | % of company | % of portfolio | Change | As of |
|---|---|---|---|---|---|---|
| Space Exploration Technologies Corp NASDAQ:SPCX | 923K | US$139M | 0.01% | 25.4% | −476K | Sep 30, 2026 |
| Aktis Oncology, Inc. NASDAQ:AKTS | 3.34M | US$65.1M | 6.2% | 11.9% | +274K | Sep 30, 2026 |
| Latigo Biotherapeutics, Inc. NASDAQ:LTGO | 3.6M | US$60.1M | 5.4% | 11.0% | New | Sep 30, 2026 |
| Larimar Therapeutics, Inc. NASDAQ:LRMR | 9.92M | US$31.7M | 9.5% | 5.8% | +761K | Sep 30, 2026 |
| Electra Therapeutics, Inc. NASDAQ:ETRA | 2.61M | US$29.4M | 4.2% | 5.4% | New | Sep 30, 2026 |
| Nuveen Churchill Direct Lending Corp. NYSE:NCDL | 2.14M | US$24.1M | 4.4% | 4.4% | No change | Sep 30, 2026 |
| Cullinan Therapeutics, Inc. NASDAQ:CGEM | 1.4M | US$21.5M | 3.9% | −140K | Sep 30, 2026 | |
| Blue Owl Capital Corporation NYSE:OBDC | 2.05M | US$21.5M | 0.42% | 3.9% | No change | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. NASDAQ:OBX | 1.48M | US$20.4M | 2.4% | 3.7% | New | Sep 30, 2026 |
| Sagimet Biosciences Inc. - Series A NASDAQ:SGMT | 1.13M | US$11.1M | 1.6% | 2.0% | −135K | Sep 30, 2026 |
| Dell Technologies Inc. NYSE:DELL | 19,342 | US$10.4M | <0.01% | 1.9% | −13,619 | Sep 30, 2026 |
| Holley Inc. NYSE:HLLY | 4.38M | US$10.3M | 3.6% | 1.9% | No change | Sep 30, 2026 |
| Conduent Incorporated NASDAQ:CNDT | 5.04M | US$7.86M | 3.2% | 1.4% | No change | Sep 30, 2026 |
| Deep Fission, Inc. NASDAQ:FISN | 1.33M | US$6.84M | 2.3% | 1.2% | No change | Sep 30, 2026 |
| Aquestive Therapeutics, Inc. NASDAQ:AQST | 1.39M | US$6.44M | 1.1% | 1.2% | +448K | Sep 30, 2026 |
| Immix Biopharma, Inc. NASDAQ:IMMX | 602K | US$6.26M | 0.72% | 1.1% | +164K | Sep 30, 2026 |
| MapLight Therapeutics, Inc. NASDAQ:MPLT | 556K | US$5.67M | 1.3% | 1.0% | −174K | Sep 30, 2026 |
| Veradermics, Incorporated NYSE:MANE | 45,000 | US$5.46M | 0.11% | 1.00% | New | Sep 30, 2026 |
| ImageneBio, Inc. NASDAQ:IMA | 1.14M | US$5.2M | 9.1% | 0.95% | +217K | Sep 30, 2026 |
| Opus Genetics, Inc. NASDAQ:IRD | 970K | US$4.69M | 1.0% | 0.86% | New | Sep 30, 2026 |
| Corvus Pharmaceuticals, Inc. NASDAQ:CRVS | 359K | US$4.13M | 0.43% | 0.75% | −250K | Sep 30, 2026 |
| Rezolute, Inc. NASDAQ:RZLT | 935K | US$3.87M | 0.97% | 0.71% | New | Sep 30, 2026 |
| Artiva Biotherapeutics, Inc. NASDAQ:ARTV | 530K | US$3.77M | 1.1% | 0.69% | −345K | Sep 30, 2026 |
| Cybin, Inc. NEO:HELP | 288K | US$3.54M | 0.39% | 0.65% | +228K | Sep 30, 2026 |
| Achieve Life Sciences, Inc. NASDAQ:ACHV | 413K | US$3.34M | 0.38% | 0.61% | New | Sep 30, 2026 |
| Procore Technologies, Inc. NYSE:PCOR | 64,030 | US$3.31M | 0.60% | New | Sep 30, 2026 | |
| Compass Therapeutics, Inc. NASDAQ:CMPX | 3.15M | US$3.28M | 1.8% | 0.60% | −470K | Sep 30, 2026 |
| Palvella Therapeutics, Inc. NASDAQ:PVLA | 23,003 | US$3.17M | 0.16% | 0.58% | −13,256 | Sep 30, 2026 |
| Zura Bio Limited NASDAQ:ZURA | 735K | US$3.06M | 0.56% | New | Sep 30, 2026 | |
| LENZ Therapeutics, Inc. NASDAQ:LENZ | 782K | US$3M | 2.5% | 0.55% | +25,000 | Sep 30, 2026 |
| Starwood Property Trust Inc. NYSE:STWD | 196K | US$2.65M | 0.05% | 0.48% | No change | Sep 30, 2026 |
| Pyxis Oncology, Inc. NASDAQ:PYXS | 1M | US$2.33M | 0.84% | 0.43% | New | Sep 30, 2026 |
| Viridian Therapeutics, Inc. NASDAQ:VRDN | 100K | US$2.06M | 0.38% | −160K | Sep 30, 2026 | |
| Netskope, Inc. NASDAQ:NTSK | 97,148 | US$1.69M | 0.04% | 0.31% | New | Sep 30, 2026 |
| ServiceTitan, Inc. NASDAQ:TTAN | 25,360 | US$1.67M | 0.30% | New | Sep 30, 2026 | |
| First Advantage Corporation NASDAQ:FA | 88,665 | US$1.58M | 0.29% | New | Sep 30, 2026 | |
| Eledon Pharmaceuticals, Inc. NASDAQ:ELDN | 567K | US$1.43M | 0.67% | 0.26% | No change | Sep 30, 2026 |
| WW International, Inc. NASDAQ:WW | 71,277 | US$1.1M | 0.71% | 0.20% | −13,122 | Sep 30, 2026 |
| Marker Therapeutics, Inc. NASDAQ:MRKR | 554K | US$593K | 3.3% | 0.11% | No change | Sep 30, 2026 |
| Fold Holdings, Inc. NASDAQ:FLD | 857K | US$454K | 1.6% | 0.08% | No change | Sep 30, 2026 |
| Piper Sandler Companies NYSE:PIPR | 2,428 | US$160K | <0.01% | 0.03% | No change | Sep 30, 2026 |
| Caris Life Sciences, Inc. NASDAQ:CAI | 4,711 | US$144K | <0.01% | 0.03% | No change | Sep 30, 2026 |
| Energy Transfer LP NYSE:ET | 5,326 | US$105K | <0.01% | 0.02% | No change | Sep 30, 2026 |
| Vodafone Group Public Limited Company LSE:VOD | 5,371 | US$86,769 | 0.02% | No change | Sep 30, 2026 | |
| Tactical Resources Corporation NASDAQ:TREO | 11,250 | US$29,882 | 0.08% | <0.01% | New | Sep 30, 2026 |
| Monte Rosa Therapeutics, Inc. NASDAQ:GLUE | 2,392 | US$28,537 | <0.01% | New | Sep 30, 2026 | |
| AEON Biopharma, Inc. AMEX:AEON | 42,353 | US$12,706 | 0.05% | <0.01% | No change | Sep 30, 2026 |
| Katapult Holdings, Inc. NASDAQ:KPLT | 5,421 | US$3,547 | <0.01% | <0.01% | No change | Sep 30, 2026 |